UBE2D4
Ubiquitin-conjugating enzyme E2 D4
Also known as: HBUCE1, UB2D4_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y2X8
- Gene
- UBE2D4
- Ensembl
- ENSG00000078967
- Chromosome
- 7
- Canonical length
- 147 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Cytosol
OverviewNCBI Gene
Enables ubiquitin conjugating enzyme activity. Involved in protein polyubiquitination. Acts upstream of or within protein ubiquitination. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
147 residues, UniProt reviewed canonical sequence.
>Q9Y2X8|UBE2D4
1 MALKRIQKEL TDLQRDPPAQ CSAGPVGDDL FHWQATIMGP NDSPYQGGVF FLTIHFPTDY
61 PFKPPKVAFT TKIYHPNINS NGSICLDILR SQWSPALTVS KVLLSICSLL CDPNPDDPLV
121 PEIAHTYKAD REKYNRLARE WTQKYAMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against UBE2D4 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 30 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 30 nTPM
- tongue: 26 nTPM
- hippocampal formation: 11 nTPM
- amygdala: 11 nTPM
- cerebral cortex: 11 nTPM
- heart muscle: 11 nTPM
Single-cell type
- cardiomyocytes: 100 nCPM
- epicardial cells: 48 nCPM
- myonuclei: 42 nCPM
- esophageal suprabasal cells: 37 nCPM
- breast lactating cells: 36 nCPM
- hofbauer cells: 35 nCPM
Immune cell
- non-classical monocyte: 29 nTPM
- intermediate monocyte: 24 nTPM
- eosinophil: 18 nTPM
- naive CD4 T-cell: 16 nTPM
- myeloid DC: 15 nTPM
- classical monocyte: 15 nTPM
Brain region
- cerebellum: 20 nTPM
- white matter: 16 nTPM
- hippocampal formation: 16 nTPM
- basal ganglia: 16 nTPM
- medulla oblongata: 16 nTPM
- spinal cord: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.47
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.92
- DepMap mean gene effect
- -0.2
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 10% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- protein K11-linked ubiquitination
- protein K27-linked ubiquitination
- protein K29-linked ubiquitination
- protein K48-linked ubiquitination
- protein K6-linked ubiquitination
- protein K63-linked ubiquitination
- protein ubiquitination
- ubiquitin-dependent protein catabolic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of UBE2D4 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads UBE2D4 as an antibody target. Whether an autoantibody or antibody against UBE2D4 could matter depends on whether native UBE2D4 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
UBE2D4 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label UBE2D4 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...